Monte Rosa Therapeutics Inc

GLUENASDAQ · USD
12.62USD+0.36 (+2.94%)
1310

Monte Rosa Therapeutics Inc (GLUE) Option Chain

As of September 21, 2026, Monte Rosa Therapeutics Inc is trading at $12.62, a +2.94% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 117.1%. IV Rank is 56%.

Read more

Tracking the GLUE option chain helps you see every strike and expiry on Monte Rosa Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Monte Rosa Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of GLUE options activity at a glance. Use our scanner to monitor the GLUE option chain in real time and filter for the GLUE options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For GLUE stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the GLUE option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where GLUE stock options are being actively traded and where they are not.

Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing protein for the treatment of Myc-driven cancers. The company also develops CDK2 to treat ovarian, uterine, and breast cancers; NEK7 for the treatment of inflammatory diseases, such as Crohn's disease, neurodegenerative disease, diabetes, and liver disease; VAV1, a target protein for autoimmune diseases; and BCL11A, a therapeutically-relevant protein in hemoglobinopathies.

Monte Rosa Therapeutics, Inc. was incorporated in 2019 and is headquartered in Boston, Massachusetts.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Monte Rosa Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen GLUE options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of GLUE stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile76.19% Elevated
  • Market cap (M$)1,046
  • 52 weeks high-52.43%
  • 52 weeks low96.79%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$28.50
    125.83% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-05
  • P/E
  • Future P/E
  • EPS (ttm)-1.91
  • EPS growth next 5 years

As of September 21, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
7.0900-0.375.122.507.007.50-38.834.200.004.200192.91
29.97202.282.624.9010.00-18.430.850.000.850970.03
58.21151,2900.980.121.001.2012.50+1.960.702.650.001.68091841.79
78.972,092260.530.000.150.9015.00+22.351.505.502.381.12020821.03
90.513004.200.004.2017.50+42.743.107.904.880.6201619.49

As of September 21, 2026

Scan the full option chain in one place

Browse the full GLUE option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial